Products

We’re always working to identify unique collaborative opportunities in the ophthalmic space and have the experience and agility to execute.

Preclinical

Phase 1

Phase 2

Phase 3

Approved

ZERVIATE

(cetirizine ophthalmic solution) 0.24% 

Allergic Conjunctivitis

FLAREX®

(fluorometholone acetate ophthalmic suspension) 0.1%

Ocular Inflammation of the conjunctiva, cornea and anterior segment

TOBRADEX® ST

(tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05%

Ocular inflammation with presence or risk of infection

NATACYN®

(natamycin ophthalmic suspension) 5.0%

Treatment of fungal blepharitis, conjunctivitis and keratisis

FRESHKOTE® PRESERVATIVE FREE (PF)

(polyvinyl alcohol/povidone) 2.7%/2.0%

Temporary relief of symptoms of dry eye

EYEV-118

(undisclosed – corticosteroid/antibiotic combination)  

EYEV-218

(undisclosed – corticosteroid)

EYEV-318

(undisclosed – corticosteroid)

TobraDex ST logo

TOBRADEX® ST advanced suspension technology makes the difference when treating steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists (blepharitis and meibomian gland dysfunction (MGD)). 

Using a combination therapy enhanced with XanGen™ provides an optimized and consistent delivery of tobramycin and dexamethasone in every drop. The suspension technology (ST) makes the difference with increased viscosity by allowing longer retention of drug concentration on the eye resulting in greater bioavailability than TobraDex®.

Zerviate logo

ZERVIATE with Hydrella™ delivers the proven power of Zyrtec® in a new ocular formulation designed to alleviate ocular itch in your moderate to severe patients. ZERVIATE™ safely delivers a rapid 3- minute onset of action and 8-hour duration, while the Hydrella system provides comfort with each drop. Alleviate with ZERVIATE

FLAREX® treats ocular surface and anterior segment inflammation with precision potency, delivering the optimal balance of efficacy and safety to help eye care professionals meet the needs of their patients. As the first and only acetate derivative of fluorometholone, FLAREX® has demonstrated efficacy SUPERIOR to FML® and equivalent to Pred Forte® 1.0% in treating ocular surface inflammation WITHOUT an increase in side effects.

Natacyn logo

NATACYN® is the first and only FDA approved ophthalmic antifungal with over 40 years of proven safety and efficacy. With over 27 countries relying on NATACYN® to treat fungal infections caused by susceptible organisms including Fusarium solani the World Health Organization (WHO) has placed NATACYN® on the Essential Medicines list.

Freshkote PF logo

FRESHKOTE® Preservative Free (PF) gives nurturing relief to patients suffering from dry eye symptoms, while reducing further irritation.

FRESHKOTE® PF’s unique patented polymer blend of polyvinvyl alcohol and povidone is designed to support ALL layers of the tear film and was scientifically developed to result in high oncotic pressure when on the ocular surface.